1Casa AJ, Dearth RK, Litzenburger BC, et al. The type Ⅰ insulin-like growth factor receptor pathway: a key player in cancer therapeutic resistance. Front Biosci, 2008, 13: 3273-3287.
2Gauguin L, Klaproth B, Sajid W, et al. Structural basis for the lower affinity of the insulin-like growth factors for the insulin receptor.J Biol Chem, 2008, 283(5): 2604-2613.
9Mauras N, Martinez V, Rini A, et al. Recombinant human insulin-like growth factor Ⅰ has significant anabolic effects in adults with growth hormone receptor deficiency: studies on protein, glucose, and lipid metabolism.J Clin Endocrinol Metab, 2000, 85(9): 3036-3042.
10Samani AA, Yakar S, LeRoith D, et al. The role of the IGF system in cancer growth and metastasis: overview and recent insights. Endocr Key, 2007, 28(1): 20-47.
